Peptide Therapy Safely Lowers Blood Triglycerides in Animals (1 of 2) (IMAGE)
Caption
Four microsecond-long molecular dynamics simulation of apolipoprotein C-II interacting with a trilayer, mimicking a triglyceride-rich lipoprotein. Carbon atoms of triglycerides and phospholipids are shown in yellow and gray, respectively. N-terminal, middle, and C-terminal domains of apoC-II are shown in blue, cayan, and red, respectively. This material relates to a paper that appeared in the Jan. 29, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by A. Wolska at National Heart, Lung, and Blood Institute, NIH in Bethesda, MD; and colleagues was titled, "A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides."
Credit
[Credit: Mohsen Pourmousa, National Institutes of Health]
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content